Attenuated Single Neuron and Network Hyperexcitability Following MicroRNA-134 Inhibition in Mice with Drug-Resistant...

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Acquired epilepsies involve complex pathophysiology, suggesting multi-targeting therapeutic strategies.
• MicroRNAs (miRNAs) are key regulators of gene expression, influencing numerous protein-coding transcripts.
• Previous studies indicated antisense oligonucleotides targeting microRNA-134 (Ant-134) could suppress seizures post-status epilepticus.

Purpose of the Study:

• To investigate the efficacy of Ant-134 in reducing spontaneous seizures in established epilepsy models.
• To elucidate the underlying electrophysiological mechanisms of Ant-134's anti-seizure effects.

Main Methods:

• Intracerebroventricular microinjection of Ant-134 in male mice with kainic acid-induced status epilepticus.
• Ex vivo electrophysiological recordings from hippocampal slices (CA1 neurons) 2-4 days post-injection.
• Assessment of action potential bursts, excitatory post-synaptic current frequencies, and Schaffer collateral stimulation responses.

Main Results:

• Ant-134 significantly reduced the occurrence of spontaneous seizures in epileptic mice.
• Electrophysiological analyses revealed reduced single neuron excitability, including decreased action potential bursts and excitatory post-synaptic current frequencies in CA1 neurons.
• Network hyperexcitability was attenuated, evidenced by reduced pro-excitatory responses to Schaffer collateral stimulation.

Conclusions:

• Inhibiting miR-134 effectively reduces both single neuron and network hyperexcitability in epilepsy models.
• These findings provide further support for targeting miR-134 as a therapeutic strategy for drug-resistant epilepsies.
• The study highlights the potential of miRNA-based therapies for managing epilepsy by modulating neuronal excitability.